By Simon Estcourt Consider the following scenarios. You’ve got an oncology drug in the pipeline that’s showing great promise. Results from your clinical trials are…
By Andrew Emmett In 2007, Congress codified many established pharmaceutical risk management practices through the establishment of risk evaluation and mitigation strategies (REMS) under the…